Literature DB >> 10403928

Spontaneous labour at term is associated with fetal monocyte activation.

A Steinborn1, C Sohn, C Sayehli, A Baudendistel, D Hüwelmeier, C Solbach, E Schmitt, M Kaufmann.   

Abstract

The aetiology of both term and preterm labour remains incompletely understood. Maternal infectious diseases as well as intra-uterine infections were shown to be a well established cause of uncontrollable preterm delivery, indicating that inflammatory reactions, regulated by maternal immunecompetent cells, are implicated in labour-promoting mechanisms. To investigate the possibility that the activation of the fetal immune system may be involved in labour induction, we examined cytokine production patterns of different cord blood cell populations obtained from neonates after spontaneous onset of normal term labour and vaginal delivery (n = 25), vaginal delivery but induced term labour (n = 17), and preterm delivery because of uncontrollable labour (n = 27, 20 patients received corticoid treatment for fetal lung maturation), in comparison with cells obtained from neonates after elective term caesarean delivery in the absence of labour (n = 15). Our results demonstrate that spontaneous term labour, but not induced term labour, was associated with significantly increased IL-6 production by myelomonocytic cell populations. Preterm delivery due to uncontrollable labour with resistance to tocolysis was not associated with increased IL-6 production by fetal myelomonocytic cells. Two-colour flow cytometry combined with intracellular cytokine staining was used to identify fetal monocytes as sources of labour-associated IL-6 release at term. We did not find any activation of cord blood T cells in association with spontaneous term or uncontrollable preterm labour. Therefore, fetal T cell responses may not cause monocyte activation. Our results suggest that increased release of IL-6 from fetal monocytes is involved in mechanisms promoting normal term, but not preterm labour, and that mechanisms inducing term and preterm labour are completely different.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403928      PMCID: PMC1905473          DOI: 10.1046/j.1365-2249.1999.00938.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene.

Authors:  A Scaradavou; C Carrier; N Mollen; C Stevens; P Rubinstein
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

2.  Identification of placental cytokine-producing cells in term and preterm labor.

Authors:  A Steinborn; C von Gall; R Hildenbrand; H J Stutte; M Kaufmann
Journal:  Obstet Gynecol       Date:  1998-03       Impact factor: 7.661

Review 3.  Th1-type immunity is incompatible with successful pregnancy.

Authors:  R Raghupathy
Journal:  Immunol Today       Date:  1997-10

4.  Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.

Authors:  J X Qian; S M Lee; Y Suen; E Knoppel; C van de Ven; M S Cairo
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

5.  Immunmodulating cytokines induce term and preterm parturition.

Authors:  A Steinborn; M Kühnert; E Halberstadt
Journal:  J Perinat Med       Date:  1996       Impact factor: 1.901

6.  High level interleukin-12 production, but diminished interferon-gamma production, by cord blood mononuclear cells.

Authors:  M E Scott; M Kubin; S Kohl
Journal:  Pediatr Res       Date:  1997-04       Impact factor: 3.756

7.  Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants.

Authors:  J Hitti; M A Krohn; D L Patton; P Tarczy-Hornoch; S L Hillier; E M Cassen; D A Eschenbach
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

8.  Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term.

Authors:  T Roos; T R Martin; J T Ruzinski; D J Leturcq; S L Hillier; D L Patton; D A Eschenbach
Journal:  Am J Obstet Gynecol       Date:  1997-11       Impact factor: 8.661

9.  Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

Authors:  G P Sacks; K Studena; K Sargent; C W Redman
Journal:  Am J Obstet Gynecol       Date:  1998-07       Impact factor: 8.661

10.  Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection.

Authors:  A Steinborn; H Günes; S Röddiger; E Halberstadt
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

View more
  13 in total

1.  The relation between pre-eclampsia at term and neonatal encephalopathy.

Authors:  L Impey; C Greenwood; O Sheil; K MacQuillan; M Reynolds; C Redman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

2.  Influence of Gestational Age, Cesarean Section and Hematocrit on lnterleukin-8 Concentrations in Plasma and Detergent-Lysed Whole Blood of Noninfected Newborns.

Authors:  Felix Neunhoeffer; Diana Lipponer; Martin Eichner; Christian F Poets; Annette Wacker; Thorsten W Orlikowsky
Journal:  Transfus Med Hemother       Date:  2011-05-13       Impact factor: 3.747

3.  Cell-associated interleukin-8 in cord blood of term and preterm infants.

Authors:  J Dembinski; D Behrendt; A Heep; C Dorn; J Reinsberg; P Bartmann
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

4.  Phenotypic and functional analysis of human T lymphocytes in early second- and third-trimester fetuses.

Authors:  Y Zhao; Z-P Dai; P Lv; X-M Gao
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

5.  Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome.

Authors:  Sun Kwon Kim; Roberto Romero; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Pooja Mittal; Offer Erez; Edi Vaisbuch; Francesca Gotsch; Percy Pacora; Lami Yeo; Maria Teresa Gervasi; Ronald F Lamont; Bo Hyun Yoon; Sonia S Hassan
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

6.  The microbiota influences cell death and microglial colonization in the perinatal mouse brain.

Authors:  Alexandra Castillo-Ruiz; Morgan Mosley; Arlene J George; Lamiyah F Mussaji; Evan F Fullerton; Elara M Ruszkowski; Andrew J Jacobs; Andrew T Gewirtz; Benoit Chassaing; Nancy G Forger
Journal:  Brain Behav Immun       Date:  2017-09-07       Impact factor: 7.217

7.  CD71+ erythroid cells from neonates born to women with preterm labor regulate cytokine and cellular responses.

Authors:  Derek Miller; Roberto Romero; Ronald Unkel; Yi Xu; Felipe Vadillo-Ortega; Sonia S Hassan; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2018-02-01       Impact factor: 4.962

8.  Surge of immune cell formation at birth differs by mode of delivery and infant characteristics-A population-based cohort study.

Authors:  Titus Schlinzig; Stefan Johansson; Olof Stephansson; Lennart Hammarström; Rolf H Zetterström; Ulrika von Döbeln; Sven Cnattingius; Mikael Norman
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

Review 9.  The possible correlation between the patient's immune tolerance level during cesaerean section and the incidence of subsequent emergency peripartum hysterectomy.

Authors:  Lukasz Wicherek; Krystna Galazka
Journal:  Clin Dev Immunol       Date:  2007

10.  Associations of birth mode with cord blood cytokines, white blood cells, and newborn intestinal bifidobacteria.

Authors:  Isabel Cristina Ribas Werlang; Noel Theodore Mueller; Aline Pizoni; Henrique Wisintainer; Ursula Matte; Sergio Hofmeister de Almeida Martins Costa; Jose Geraldo Lopes Ramos; Marcelo Zubaran Goldani; Maria Gloria Dominguez-Bello; Helena Ayako Sueno Goldani
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.